A Bitter Pill to Swallow: The Challenge of Medication Nonadherence in Systemic Lupus Erythematosus.
Shivani GargLaura C PlantingaPublished in: The Journal of rheumatology (2024)
Systemic lupus erythematosus (SLE) is the most common life-threatening autoimmune disease and a leading cause of mortality among young women of Black race and Hispanic ethnicity. 1 Treatment of SLE is complex, requiring immune-altering medicines to reduce disease activity and prevent disease-related damage.